Foreign multinational drug corporations predominated whole anti-cancer markets

According to a survey conducted by Medicalspace Co., a cyber medical information company from Aug. to Nov. last year over 20 leading general hospitals (800 beds on average) (President: Mr. LeeByung-wook, www.medicalspace.co.kr), the anti-cancer drug market of Korea was predominated by the foreign multinational drug corporations, and "Taxol" of BMS ranked the top out of the total...